The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival

Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Caruso, Francesca P., Sa, Jason K., Justesen, Sune, Nam, Do-Hyun, Sims, Peter, Ceccarelli, Michele, Lasorella, Anna, Iavarone, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478916/
https://www.ncbi.nlm.nih.gov/pubmed/31044160
http://dx.doi.org/10.1038/s42003-019-0369-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478916/
https://www.ncbi.nlm.nih.gov/pubmed/31044160
http://dx.doi.org/10.1038/s42003-019-0369-7

Ejemplares similares